Benchmark helps deliver improved healthcare products and welfare services to the global aquaculture and livestock industries. Rising demand from clients for its products and services to manage sustainability practice and performance underlines BMK's opportunity for significant organic and external growth.
Sustainable growth through consistent delivery
At the recent Capital Markets Day CEO Trond Williksen outlined Benchmark’s strategy: to drive...
Read moreQ3 update: Positive outlook in uncertain times
Benchmark’s results for the FY22 Q3 (April-June) period showed robust sales plus adjusted EBITDA...
Read more
Financial update highlights strong outlook
Benchmark has reported a fourth sequential quarter of revenue and AEBITDA profit growth in the...
Read more
Strong outlook in uncertain times
Benchmark’s recent Q1 FY22 results highlighted strong operating trends in its three business areas...
Read more
Strong performance and improving outlook
Benchmark Holdings’ FY21 and particularly its Q4 (July to September) results confirmed the strong...
Read more
Benchmark Holdings - Strong Q3 for Nutrition and Genetics
Benchmark Holdings’ recent Q3 (March-June) results show strong revenue and profit growth in its...
Read more
Cleared to launch BMK08 / Ectosan Vet in Norway
Norway’s Medicines Agency (NoMA) has approved Benchmark Holdings’ parasiticide BMK08 (imidacloprid)...
Read moreRegister to be first
Get research on the companies that interest you straight to your inbox
